Gulf & Middle East · Regional markets · Argaam
Almoosa Health: Q3 Loss Driven by Non-Cash Accounting Impact of Derivative Valuation, While Core Operations Remain Profitable and Expansion Plans Stay on Track
Almoosa Health Company reported a non-cash loss of SAR 81.9 million in the third quarter of 2026, resulting from the mark-to-market (MTM) valuation of ...
Read the full article on Argaam Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.argaam.com)

